Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Assets (2017 - 2025)

Historic Assets for Serina Therapeutics (SER) over the last 9 years, with Q3 2025 value amounting to $12.4 million.

  • Serina Therapeutics' Assets rose 6695.36% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 6695.36%. This contributed to the annual value of $6.7 million for FY2024, which is 2502.23% down from last year.
  • Latest data reveals that Serina Therapeutics reported Assets of $12.4 million as of Q3 2025, which was up 6695.36% from $8.9 million recorded in Q2 2025.
  • In the past 5 years, Serina Therapeutics' Assets registered a high of $12.5 million during Q1 2023, and its lowest value of $2.0 million during Q3 2022.
  • Moreover, its 5-year median value for Assets was $6.7 million (2025), whereas its average is $6.9 million.
  • As far as peak fluctuations go, Serina Therapeutics' Assets crashed by 4658.4% in 2021, and later skyrocketed by 50806.77% in 2023.
  • Over the past 5 years, Serina Therapeutics' Assets (Quarter) stood at $3.2 million in 2021, then grew by 2.76% to $3.2 million in 2022, then surged by 176.7% to $9.0 million in 2023, then dropped by 25.02% to $6.7 million in 2024, then surged by 84.61% to $12.4 million in 2025.
  • Its Assets was $12.4 million in Q3 2025, compared to $8.9 million in Q2 2025 and $6.7 million in Q1 2025.